Diabetes care is undergoing a major transformation driven by GLP-1 receptor agonists, which have expanded beyond glycemic ...

High school science teachers can design tasks that not only develop students’ science skills but also change how they see ...

One of the persistent challenges in precision oncology is the fact that most advanced cancers are complex and highly individualized. A recent ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

Learn how medication errors lead to clinical negligence claims, from prescription failures to administration mistakes and ...

Detailed price information for Americas Gold and Silver Corp (USAS-A) from The Globe and Mail including charting and trades.

Merck has launched the Chemisphere app, a digital tool that enables scientists to easily access product documentation and ...

Professor Johan Verbraecken, shares insights on a recent ERS consensus statement on advanced telemedicine in obstructive ...

Americas Gold and Silver is pleased to announce strong exploration drilling results at the Galena Complex driving significant growth in the vicinity of the recently discovered high-grade 034 Vein.

As an adjunctive treatment, empagliflozin improves glycaemic control in patients with HNF1A-related maturity-onset diabetes ...

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...